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Abstract 
Macroautophagy was originally discovered as a nutrient salvage pathway during starvation. By 
now it has not only become clear that degradation of cytoplasmic constituents via transport by 
autophagosomes to lysosomes can be used for innate and adaptive immunity, but that the core 
machinery assists antigen presentation to the immune system by a variety of vesicular transport 
pathways. All of these rely on the presentation of small protein waste fragments, which are 
generated by a variety of catabolic pathways, including macroautophagy, on major 
histocompatibility complex (MHC) molecules. In this review, we will point out how classical 
macroautophagy, as well as phagocytosis and exocytosis, which both benefit from the core 
autophagic machinery, assist in antigen presentation on MHC class I and II molecules to CD8+ 
and CD4+ T cells, respectively. Finally to high-light that macroautophagy is always intimately 
interconnected with cell death in addition to the various supported vesicular transport function, 
its role in lymphocyte, especially T cell, development and function will be discussed. From this 
body of work a picture is emerging that the core machinery of macroautophagy can be used for 
a variety of vesicular transport pathways and to modulate cell survival, besides its classical role 
in delivering intracellular material for lysosomal degradation.   
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1. Introduction 
The adaptive immune system hinges on the orchestration by CD4+ helper T cells and cytotoxic 
CD8+ T cells as main effectors of cell-mediated immunity. These lymphocyte populations do not 
recognize antigen directly, but their T cell receptors detect antigen fragments on major 
histocompatibility (MHC) class I molecules for CD8+ T cells and MHC class II for CD4+ T cells. 
These fragments, peptides of eight or nine amino acids in length for MHC class I and longer, 
often N- and C-terminal extensions of a nonameric core sequence for MHC class II, are 
generated and loaded onto MHC class I and II molecues in different cellular compartments [1, 2]. 
MHC class I ligands are in their majority generated by the proteasome, a multicatalytic protease 
in cytosol and nucleus. In contrast, peptides for MHC class II loading are primarily produced in 
lysosomes. Loading of MHC class I and II molecules occurs primarily in the endoplasmic 
reticulum (ER) and late endosomes, respectively. Both molecules are co-translationally inserted 
into the ER. MHC class I ligands of proteasome origin get transported into the ER by the 
transporter associated with antigen processing (TAP) and loaded onto MHC class I molecules in 
the MHC class I loading complex, containing aminopeptidases, chaperones and protein disulfide 
isomerases. Once a high affinity peptide is loaded into the peptide binding groove of MHC class 
I, the complex is transported to the cell surface for CD8+ T cell recognition. Peptide binding to 
MHC class II molecules in the ER is prevented by the chaperone invariant chain (Ii), which 
blocks the peptide binding groove and contains in its cytosolic domain motifs that will facilitate 
the transport to late endosomes, either via the cell membrane or directly. These late endosomes 
that are equipped with the MHC class II loading machinery are called MHC class II containing 
compartments (MIICs). Lysosomal proteolysis within these compartments degrades Ii until only 
the peptide binding groove contains the last Ii remnant, called MHC class II associated invariant 
chain peptide (CLIP). CLIP is then exchanged for a high affinity peptide with the help of the 
chaperone HLA-DM or H2-M. In some cell types like B cells the negative regulator HLA-DO or 
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H2-O modifies this event. MHC class II complexes, stabilized by high affinity peptides, then 
migrate to the cell surface in order to engage CD4+ T cells. 
 Access to MIICs or proteasomes, maybe even specific immunoproteasomes, decides 
how efficient antigens can be loaded onto MHC molecules for T cell stimulation. Due to their co-
localization, cytosolic and nuclear antigens are preferentially processed for MHC class I 
presentation, and endocytosed antigens efficiently reach MIICs. Thus, in the classical paradigm 
of antigen processing, intracellular antigens are loaded onto MHC class I, while extracellular 
antigens are preferentially processed for MHC class II presentation. However, there are 
exceptions to this rule. In specialized antigen presenting cells, like dendritic cells (DCs), 
extracellular antigens can gain access to MHC class I presentation. This pathway is called 
cross-presentation [3]. During cross-presentation, antigen is thought to escape from early 
endosomes or even after endosome fusion with the ER into the cytosol for proteasomal 
degradation. Vice versa, intracellular antigen fragments can be found on MHC class II molecules 
and autophagy contributes to this processing as will be discussed in the next chapter. 
 
2. Delivery of intracellular antigens for MHC class II presentation via autophagy 
Evidence of intracellular antigen processing onto MHC class II molecules originally came from 
peptide elution studies, which were aimed at characterizing the ligand repertoire that is 
presented to CD4+ T cells. These studies revealed that up to one third of eluted MHC class II 
ligands originate from cytosolic and nuclear source proteins [4-6]. MHC class II presentation of 
these cytosolic and nuclear antigens can be enhanced by starvation, which up-regulates 
macroautophagy [4]. Among these peptides, the essential autophagy proteins LC3 and 
GABARAP were found [4, 7]. These are mammalian orthologs of the ubiquitin-like autophagy 
related gene (Atg) 8 protein that get coupled to the membranes of autophagosomes, the 
characteristic double-membrane vesicles of macroautophagy, during its formation around its 
substrates [8]. This conjugation is mediated by the E3-like ligase composed of Atg5, Atg16L and 
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the ubiquitin like protein Atg12. Interestingly, Atg8 is the only macroautophagy protein that stays 
with the completed autophagosome, specifically on the inner autophagosome membrane, while 
all Atgs are recycled from the outer membrane upon autophagosome completion (Figure 1). 
Therefore, the Atg8 homologues LC3 and GABARAP are in part degraded with the 
autophagosome cargo in late endosomes or autolysosomes by lysosomal hydrolases and can 
reach MHC class II loading. Accordingly, LC3 can be used to deliver antigens to 
autophagosomes, which frequently fuse with MIICs [9]. This targeting enhances antigen 
presentation on MHC class II molecules up to 20fold [9, 10]. A physiological condition, under 
which this self-antigen processing by macroautophagy seems to play a role is thymic selection. 
Both positive and negative T cell selection was affected in Atg5 negative thymi [11]. During 
these processes intracellular self-proteins are thought to be presented on MHC class II 
molecules of thymic epithelial cells (TECs) to ensure low affinity interactions of the selected T 
cell receptors during positive selection, and eliminating high-affinity T cell receptors against self-
proteins during negative selection [12]. Macroautophagy deficiency changes the repertoire of 
MHC class II presented ligands so that some T cell receptor specificities no longer efficiently 
survive positive selection, and an autoreactive T cell repertoire emerges from faulty negative 
selection. Accordingly, autophagosomes fuse frequently with MIICs in TECs [13], and 
macroautophagy substrates, like mitochondrial proteins and LC3 fusion proteins can induce 
negative selection [14]. Thus, self-antigens gain access to MHC class II presentation in part via 
macroautophagy, and this process assists thymic T cell selection. 
 Following these indications that macroautophagy might contribute to intracellular self-
antigen loading onto MHC class II molecules, several viral and bacterial antigens have been 
investigated for their processing via macroautophagy for CD4+ T cell stimulation. Among these, 
the nuclear antigen 1 of the Epstein Barr virus (EBNA1) was found to be intracellularly 
processed for MHC class II presentation [15]. This processing involved lysosomal degradation, 
and upon inhibition of lysosome acidification EBNA1 accumulated in double membrane vesicles 
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[16]. Moreover, siRNA mediated silencing of Atg12 compromised EBNA1 specific CD4+ T cell 
recognition of EBV infected B cells [16]. EBNA1 processing for MHC class II presentation was 
enhanced after blocking its access to the nucleus by mutating the nuclear localization domain of 
EBNA1 [17]. This also broadened macroautophagic antigen processing to additional EBNA1 
epitopes. Therefore, physiological levels of EBNA1 are processed for MHC class II presentation 
by macroautophagy.  
 Apart from this viral protein, bacterial antigens are processed via this pathway. The 
transposon-derived neomycin phosphotransferase II (NeoR) gets intracellularly processed by 
lysosomal hydrolysis for MHC class II presentation [18]. This processing is sensitive to 
pharmacological macroautophagy inhibitors, and influenza hemagglutinin epitope fusion to NeoR 
augments MHC class II presentation of this epitope [10, 18]. Interestingly, forced nuclear 
localization of NeoR does not compromise macroautophagy mediated processing of this antigen 
for MHC class II presentation [19]. Therefore, nuclear localization might not protect from 
macroautophagy for all antigens in all cellular backgrounds similarly well. Nevertheless, cytosolic 
localization probably favors access of antigen to autophagosomes and processing for MHC 
class II presentation via this pathway. Accordingly, proteins that are injected into the cytosol by 
bacteria have been described to fall prey to macroautophagy, followed by MHC class II 
presentation. Along these lines mycobacterial Ag85B is better presented after macroautophagy 
stimulation by MHC class II molecules of DCs, which then upon adoptive transfer prime more 
efficiently CD4+ T cell responses in vivo [20]. Furthermore, antigens fused to YopE, a Yersinia 
protein that is injected into the cytosol, are intracellularly processed for MHC class II 
presentation by a mechanism involving lysosomes and macroautophagy [21]. Thus, bacterial 
antigens, especially those that escape endosomes, can be processed via macroautophagy for 
MHC class II presentation. 
 In addition to this role for macroautophagy in intracellular antigen delivery to MIICs, 
another autophagic pathway has been implicated in autoantigen delivery for MHC class II 
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presentation. This pathway is called chaperone-mediated autophagy (CMA) and transports 
cytosolic proteins for degradation into lysosomes via a translocon in the lysosomal membrane 
[22]. While this pathway might be avoided by pathogens due to its signal peptide dependency, 
whose motifs could be easily mutated in pathogen-derived proteins, it has been implicated in 
antigen processing of autoantigens onto MHC class II molecules. Glutamate decarboxylase 65 
(GAD65) and the mutant human immunoglobulin  light chain SMA, autoantigens in diabetes 
mellitus and autoimmune hepatitis, respectively, were found to be better intracellularly 
processed for MHC class II presentation after overexpression of Lamp2a, a lysosomal 
transmembrane protein that is an integral part of the CMA translocon [23]. Thus, autoantigens 
that carry a signal peptide for CMA can be intracellularly processed for MHC class II 
presentation by pathways independent of macroautophagy. 
  
3. Modification of extracellular antigen processing for MHC class II presentation by 
autophagy 
Consistent with this contribution of macroautophagy to antigen processing for MHC class II 
antigen presentation, diminished herpes simplex virus (HSV) specific CD4+ T cell responses and 
compromised immune control of HSV was observed in mice with Atg5 deficient CD11c+ cells, 
presumably DCs [24]. However, in this study it was also noted that macroautophagy deficient 
DCs presented different formulations of extracellular antigen less efficiently to CD4+ T cells, and 
that the acquisition of active lysosomal hydrolases by endosomes was delayed in the absence of 
macroautophagy. These findings were consistent with an earlier report, suggesting that the core 
machinery of macroautophagy, which executes the Atg8 lipidation, was involved in phagosome 
maturation [25]. This study suggested that cargo that engages pathogen-associated molecular 
pattern (PAMP) receptors, like TLR2, recruits the Atg8 ortholog LC3 to the phagosomal 
membrane that surrounds it after uptake (Figure 1). Furthermore, this LC3 associated 
phagocytosis (LAP) was suggested to accelerate fusion with lysosomes and degradation of the 
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endocytosed cargo. Following this initial observation, also uptake of whole cells, so called 
entosis, was shown to engage LAP [26]. Furthermore, TIM4, a receptor involved in the uptake of 
apoptotic cells, and Dectin-1, a receptor that recognizes fungal cell wall components, were also 
shown to stimulate LAP [27, 28]. Dectin-1 mediated antigen uptake was, moreover, shown to 
enhance MHC class II presentation via LAP [28]. However, all these studies suggested that LAP 
accelerates phagocytosed cargo degradation, yet MHC class II antigen presentation had 
previously been shown to benefit from attenuated endosomal degradation [29, 30]. Therefore, 
future studies will have to define if the LAP vesicles that lead to MHC class II antigen 
presentation also show accelerated maturation, and, more generally, by which molecular 
mechanisms LC3 conjugation to the phagosomal membrane modulates the fate of LAP vesicles. 
 In addition to the regulation of phagocytosis by the molecular core machinery of 
macroautophagy, lysosomal hydrolase delivery by autophagosomes has been implicated in 
autoantigen processing for MHC class II presentation (Figure 1). Citrullinated peptides are 
generated by peptidylarginine deiminases (PADs) and recognized by the adaptive immune 
system during rheumatoid arthritis [31]. MHC class II presentation of citrullinated epitopes of the 
model antigen hen egg lysozyme has been described to require macroautophagy [32]. PAD2 
and 4, which are expressed in the immune system, seemed to be delivered by autophagsomes 
to endosomes for the generation of the citrullinated T cell epitopes. Therefore, macroautophagy 
can also assist extracellular antigen processing by modulating the content of endosomes and 
lysosomal hydrolysis. 
 
4. Contribution of autophagy to MHC class I antigen presentation 
While LAP and intracellular antigen processing by macroautophagy seem to modulate MHC 
class II presentation for a subset of antigens, the role of macroautophagy for MHC class I 
presentation is much less understood. Initially, it seemed like antigen targeting to 
autophagosomes [9] and compromising macroautophagy in DCs or TECs in vivo [11, 24] did not 
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significantly influence antigen processing for MHC class I presentation. However, recent studies 
have implicated this pathway in MHC class I antigen presentation under certain circumstances, 
so far, however, only in vitro. Initially it was reported that lysosomal degradation contributed to 
MHC class I presentation of HSV glycoprotein B late during HSV infection of human 
macrophages (>10h) [33]. This late processing was sensitive to pharmacological inhibition and 
Atg5 silencing, and could be stimulated by macroautophagy induction. These results suggested 
that during infections that compromise classical antigen processing onto MHC class I molecules 
by immune evasins, like for example TAP blocking, a vacuolar pathway might take over. This 
pathway can either transport antigen or MHC class I molecules for vacuolar loading (Figure 2). 
Similarly, TAP independent antigen processing of the human cytomegalovirus (HCMV) protein 
pUL138 for MHC class I presentation was found to require macroautophagy [34]. While, 
however, HSV gB processing was still proteasome dependent, HCMV pUL138 degradation was 
proteasome independent, suggesting that maybe an endosomal MHC class I loading 
compartment requires macroautophagy for its formation, and can receive input from lysosomal 
or proteasomal antigen processing. Supporting this notion is the recent finding that cross-
presentation of the F protein of the respiratory syncytial virus (RSV) also requires 
macroautophagy, but is independent of TAP and proceeds via lysosomal degradation [35]. 
Indeed, MHC class I molecules can reach endosomal loading also in TAP deficient cells at low 
temperatures, and then cross-presentation of exogenous antigen becomes TAP independent 
[36]. In addition to endosomal loading of viral antigens onto MHC class I molecules, a recent 
study argues in favor of a contribution of macroautophagy to endosomal processing of MHC 
class I epitopes in the case of chlamydia infection [37]. Indeed in Chlamydia infected DCs, an 
endosomal route of antigen loading onto MHC class I molecules that is both TAP and 
proteasome dependent might be supported by autophagosomes. However the contribution of 
macroautophagy in the processing of bacterial epitopes was only demonstrated by 
pharmacological inhibitors and by colocalization analysis via confocal microscopy.  Therefore, 
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this observation needs to be further substantiated by more specific macroautophagy inhibition 
targeting Atgs. Nevertheless, MHC class I molecules might be loaded endosomally under 
conditions of pathogen mediated blockade of the classical MHC class I antigen processing 
pathway. While recent studies suggest that macroautophagy supports this endosomal MHC 
class I loading, it remains so far unclear if transport of MHC class I molecules to an endosomal 
loading compartment or antigen degradation for MHC class I loading benefits from this pathway.  
 
5. Packaging of antigens via autophagy for antigen presentation 
In addition to delivery of cytoplasmic constituents for lysosomal degradation, macroautophagy 
has also been implicated in signal peptide independent secretion. Exocytosis via 
macroautophagy was first reported in yeast [38, 39]. In these studies acyl coenzyme A-binding 
protein (ACBP) was shown to exit cells in a macroautophagy dependent manner, requiring the 
fusion machinery for the plasma membrane, but not the lysosomal vacuole. Similarly, it has been 
suggested that IL-1, a cytokine that is also secreted by a non-conventional pathway, is 
released by macroautophagy mediated exocytosis [40]. Finally, amorphous extracellular 
deposits in age related macular degeneration, so called drusen, also contains autophagosome 
markers [41]. The releasing retinal pigment epithelium displays increased macroautophagy, 
decreased lysosomal activity and elevated exocytosis, which could indicate augmented 
exocytosis via macroautophagy. Such exocytosis could be beneficial for antigen cross-
presentation by packaging cytoplasmic material optimally for uptake by bystander antigen 
presenting cells (Figure 2). Along these lines it has been found that influenza A virus and tumor 
antigens were only efficiently cross-presented onto MHC class I molecules, when the antigen 
donor cells were macroautophagy competent [42, 43]. Influenza A virus blocks autophagosome 
maturation and the accumulating autophagosomes contain viral antigens [44]. This arrest could 
promote exocytosis. Similarly, autophagosomes from tumor cells lines contain tumor antigens 
[43], and the inner autophagosomal membrane plus this tumor antigen cargo could be released 
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for cross-presentation via exocytosis (Figure 2). Therefore, macroautophagy might assist the 
release of antigens for cross-presentation on MHC class I molecules to T cells. 
 
6. Regulation of lymphocyte function via autophagy 
In addition to influencing T cell education by antigen presentation during positive and negative 
selection in the thymus, macroautophagy also cell-intrinsically influences lymphocyte 
differentiation and function. Both immature T and B cells seem to require macroautophagy 
during their development [45-47]. Altered B cell differentiation in the absence of macroautophagy 
does, however, only lead to decreased B1 cell numbers [47], while overall B cell reconstitution is 
not significantly changed [45]. Upon further differentiation to plasma cells, however, 
macroautophagy is required for the maintenance of these antibody production plants [48, 49]. 
Atg5 deficient plasma cells were found to suffer from expanded ER and increased unfolded 
protein response stress, leading to their elevated cell death. In immature T cells, so called 
thymocytes, macroautophagy seems to protect from toxic reactive oxygen species (ROS) 
production by decreasing mitochondrial mass [50, 51]. Macroautophagy up-regulation for 
mitochondrial clearance seems to be achieved through activation of the transient receptor 
potential vanilloid 1 (TRPV1) via NADPH oxidase produced ROS, which activate adenosine 
monophosphate-activated protein kinase (AMPK) to inhibit mammalian target of rapamycin 
(mTOR) to activate macroautophagy [52]. In addition, ROS inhibit Atg8 deconjugation by Atg4 to 
sustain autophagosomal membrane formation [53]. In contrast to these now even 
mechanistically well understood effects of macroautophagy loss during adaptive lymphocyte 
development, it remains less clear to which extent this affects the function of these cells in the 
periphery. While it was originally reported that T cell proliferation after T cell receptor stimulation 
is compromised in the absence of macroautophagy [46], a more recent study suggested that 
mature T cells were able to expand efficiently with diminished macroautophagy [45]. Therefore, it 
seems clear that macroautophagy protects from cell death during T and B cell differentiation, but 
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its prosurvival role during adaptive lymphocyte activation seems less essential with the 
exception of plasma cell differentiation.  
 While physiological macroautophagy levels protect from cell death in most instances, too 
dramatic induction of this pathway or overexpression of some Atgs can instead compromise cell 
survival. Along these lines, macroautophagy seemed to contribute to cell death in Th2 polarized 
CD4+ T cells, which display higher autophagosome numbers than Th1 polarized CD4+ T cells 
[54]. Moreover, overexpression of Atg6 sensitizes thymocytes for apoptosis induction [55]. 
However, this observation could also be explained by the sequestration of anti-apoptotic Bcl-2 
by Atg6. Thus, macroautophagy protects from cell death during development, but can diminish 
or enhance lymphocyte function after maturation. The characteristics of immune responses with 
these different requirements for macroautophagy need to be determined in the future to predict 
the outcome of macroautophagy regulating interventions on protective or pathogenic 
lymphocytes. 
 
7. Conclusions and outlook 
Recent studies have revealed that the molecular machinery of macroautophagy does not only 
serve the purpose of transporting cytoplasmic constituents for lysosomal degradation, but also 
influences vesicular transport pathways in a broader sense. Indeed, in addition to 
autophagosome generation, macroautophagy seems to modulate endo- and exocytosis. 
Moreover, the intimate connections with the cell death machinery, exemplified by the complex 
formation of Atg6 with Bcl-2, always affects also survival of the macroautophagy regulating cell, 
in parallel to vesicular transport. Future research will need to characterize how this modular 
format of the macroautophagy machinery can be specifically recruited to fulfill these different 
tasks and how one might selectively regulate these different functions of macroautophagy for 
therapeutic benefit.   
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Figure legends 
Figure 1. Contributions of macroautophagy to MHC class II antigen processing. 
Macroautophagy can deliver intracellular antigens to MHC class II containing compartments 
(MIICs) for lysosomal antigen processing and loading of antigen fragments onto MHC class II 
molecules (top left). In addition, the macroautophagy core machinery modifies phagosomes for 
LC3-associated phagocytosis (LAP). This can facilitate extracellular antigen processing for MHC 
class II presentation (top right). Finally, macroautophagy delivers cytosolic hydrolases, like 
peptidylarginine deiminases (PADs) to endosomal compartments for antigen modification, 
resulting in MHC class II presentation of altered peptide ligands, like citrullinated peptides 
(bottom). 
 
Figure 2. Contributions of macroautophagy to MHC class I antigen processing. 
Macroautophagy in antigen donor cells facilitates better cross-presentation by presumably 
supporting antigen exocytosis. After uptake by neighboring antigen presenting cells the 
transferred antigen is processed and loaded in MHC class I cross-presenting compartments (top 
left). MHC class I molecules or extracellular antigens might reach these compartments with 
assistance of the macroautophagic core machinery (top right). In addition, intracellular antigens 
might be delivered with or without preprocessing via proteasomes to such vesicular MHC class I 
cross-presenting compartments via classical macroautophagy (bottom). 
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